Innovations Driving the Arteriovenous Malformation Market Expansion
Innovation is key to the growth of the Arteriovenous Malformation Market. Advanced embolic agents, robotic-assisted procedures, and image-guided radiosurgery are improving precision, safety, and patient outcomes.
New technologies reduce complications, shorten recovery times, and make procedures less invasive. These innovations increase adoption in high-volume hospitals and specialty centers worldwide, fueling market expansion.
Market Outlook: Valued at USD 1.1 billion in 2024, the market is expected to reach USD 2.4 billion by 2034, growing at a 7.0% CAGR.
1 View